Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Anti-SARS-CoV-2 QuantiVac ELISA (IgG)
Connect with this vendor - Learn about this product

Anti-SARS-CoV-2 QuantiVac ELISA (IgG)

  • Quantitative ELISA for the determination of the concentration of IgG antibodies against the S1 antigen (including RBD) of SARS-CoV-2 using a 6-point calibration curve
  • Excellent correlation with the WHO reference material “First WHO International Standard for anti-SARS-CoV-2 immunoglobulin” (NIBSC code: 20/136) – enables issuing of results in standardised units
  • Very good agreement of results in comparison with different neutralisation tests
  • Validated for serum, plasma and dried capillary blood as sample material
  • Fully automatable